IP Library Granted Patent US 7,186,419
Granted Patent B2
US 7,186,419 · App. 09/938,668 · Granted Mar 6, 2007

Polyacrylamide hydrogel for arthritis

Assignee: Contura SA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,186,419
App. No.
09/938,668
Granted
Mar 6, 2007
Kind
B2
Abstract

A hydrogel for use as a prosthetic device for supplementing, augmenting or replacing cartilage in the intra-articular cavity of a joint and for treatment or prevention of arthritis. The hydrogel may be a polyacrylamide hydrogel obtained by combining acrylamide and methylene bis-acrylamide. A prosthetic device comprising the polyacrylamide hydrogel is also disclosed.

Claims (14)

1. A method for replacing, mimicking or augmenting a function of cartilage, synovial fluid or both comprising administering an endoprosthesis to a joint in a mammal, wherein said endoprosthesis comprises a hydrogel, said hydrogel comprising 0.5% to 25% by weight polyacrylamide, based on the total weight of the hydrogel.

2. The method according to claim 1 , wherein the hydrogel is obtained by a process comprising combining acrylamide and methylene bis-acrylamide in a molar ratio of 150:1 to 1000:1.

3. The method according to claim 1 , wherein the hydrogel comprises less than 15% by weight polyacrylamide, based on the total weight of the hydrogel.

4. The method according to claim 3 , wherein the hydrogel comprises at least 1% by weight polyacrylamide, based on the total weight of the hydrogel.

5. The method according to claim 1 , wherein the hydrogel has a complex viscosity of about 2 to 25 Pa s.

6. The method according to claim 1 , wherein the hydrogel further comprises at least 75% by weight pyrogen-free water or saline solution.

7. The method according to claim 1 , wherein the hydrogel comprises at least 80% by weight pyrogen-free water or saline solution.

8. The method according to claim 1 , wherein the administering comprises injecting the hydrogel into an intra-articular cavity of the joint.

9. The method according to claim 1 , wherein the hydrogel is radio-labeled and the administering may be monitored by visualization.

10. The method according to claim 8 , further comprising administering hydrogel injections to excessively stressed areas of the intra-articular cavity.

11. The method according to claim 1 , wherein the hydrogel comprises at least 75% by weight pyrogen-free water.

12. The method according to claim 1 , wherein the hydrogel comprises at least 90% by weight pyrogen-free water or saline solution.

13. The method according to claim 1 , wherein the hydrogel comprises at least 75% by weight saline solution.

14. The method according to claim 1 , wherein the hydrogel has a complex viscosity of about 2 to 13 Pa s.

Assignments (4)
CERTIFICATE OF INCORPORATION ON CHANGE OF NAME Recorded Apr 21, 2021
From: CONTURA LIMITED
To: AXONICS WOMEN'S HEALTH LIMITED
Reel/Frame 055997/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2021
From: CONTURA INTERNATIONAL A/S; CONTURA A/S
To: CONTURA LIMITED
Reel/Frame 056067/0669 →
CHANGE OF NAME Recorded Jun 19, 2008
From: CONTURA SA
To: CONTURA A/S
Reel/Frame 021118/0573 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2001
From: PETERSEN, JENS
To: CONTURA SA
Reel/Frame 012337/0636 →
Continuity (2)
Provisional Application 6022808100 · Aug 25, 2000
Related Publication 20030065389A1 · Apr 3, 2003